Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Clinical trial NCT03712943 · COMPLETED
Trial details
- NCT number
- NCT03712943
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2021-09-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.